Pregnant women are advised to get vaccinated against respiratory syncytial virus (RSV) between 32 and 36 weeks of pregnancy to protect their newborns. Research suggests that getting vaccinated closer to 32 weeks provides the most efficient transfer of antibodies to the newborn. This can lead to higher and longer-lasting antibody levels in both mothers and babies. The timing of RSV vaccination during pregnancy could also impact the effectiveness of the vaccine. More studies are needed to determine the minimum antibody levels needed for protection and the added protection from breast milk of vaccinated mothers. Ultimately, vaccinating against RSV during pregnancy can help protect both mothers and newborns.
Source link